Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer.

[1]  C. Rizzi.  Statistical Methods , 2020, Springer Theses.

[2]  S Heritier,et al.  Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now? , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[4]  L. Rajmil.  Health measurement scales. A practical guide to their development and use, 3rd ed , 2005 .

[5]  T. Lane.  Partner's influence on patient preference for treatment in early prostate cancer? , 2004, BJU international.

[6]  A. Stiggelbout,et al.  Choices in oncology: factors that influence patients' treatment preference , 1994, Quality of Life Research.

[7]  R. Simes,et al.  Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed? , 2001, Journal of the National Cancer Institute. Monographs.

[8]  M. Stockler,et al.  Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile. , 2001, The Lancet. Oncology.

[9]  N. Aaronson,et al.  Comparison of patient and spouse assessments of health related quality of life in men with metastatic prostate cancer. , 2001, The Journal of urology.

[10]  N. Aaronson,et al.  Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses , 1999, British Journal of Cancer.

[11]  N. Aaronson,et al.  Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. , 1998, Journal of clinical epidemiology.

[12]  G. Lockwood,et al.  What Attitudes and Beliefs Underlie Patients' Decisions about Participating in Chemotherapy Trials? , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.

[13]  D. Osoba,et al.  The use of significant others as proxy raters of the quality of life of patients with brain cancer. , 1997, Medical care.

[14]  H. Llewellyn-Thomas,et al.  Investigating patients' preferences for different treatment options. , 1997, The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres.

[15]  N. Aaronson,et al.  Value of caregiver ratings in evaluating the quality of life of patients with cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  C. Charles,et al.  Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). , 1997, Social science & medicine.

[17]  K. McGraw,et al.  "Forming inferences about some intraclass correlations coefficients": Correction. , 1996 .

[18]  K. McGraw,et al.  Forming inferences about some intraclass correlation coefficients. , 1996 .

[19]  C. Reust,et al.  Family involvement in medical decision making. , 1996, Family medicine.

[20]  H. Llewellyn-Thomas,et al.  Cancer Patients' Evaluations of Their Current Health State , 1992, Medical decision making : an international journal of the Society for Medical Decision Making.

[21]  W. Gregory,et al.  Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. , 1990, BMJ.

[22]  D. Streiner,et al.  Health Measurement Scales: A practical guide to thier development and use , 1989 .

[23]  J. Fleiss,et al.  Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.

[24]  J. R. Landis,et al.  An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. , 1977, Biometrics.

[25]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.